BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17919499)

  • 21. Simvastatin Induces Autophagy and Inhibits Proliferation in Prostate Cancer Cells.
    Miyazawa Y; Sekine Y; Oka D; Nakazawa S; Tsuji Y; Nakayama H; Suzuki K
    Anticancer Res; 2023 Dec; 43(12):5377-5386. PubMed ID: 38030198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statins as anti-tumor agents: A paradigm for repurposed drugs.
    Tripathi S; Gupta E; Galande S
    Cancer Rep (Hoboken); 2024 May; 7(5):e2078. PubMed ID: 38711272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TIF1γ and SMAD4 regulation in colorectal cancer: impact on cell proliferation and liver metastasis.
    Wu Y; Yu B; Ai X; Zhang W; Chen W; Laurence A; Zhang M; Chen Q; Shao Y; Zhang B
    Biol Chem; 2024 Apr; 405(4):241-256. PubMed ID: 38270141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colorectal Cancer Therapy Using a
    An BC; Ryu Y; Yoon YS; Choi O; Park HJ; Kim TY; Kim SI; Kim BK; Chung MJ
    Mol Cells; 2019 Nov; 42(11):755-762. PubMed ID: 31707776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting oncogenic mutations in colorectal cancer using cryptotanshinone.
    Vundavilli H; Datta A; Sima C; Hua J; Lopes R; Bittner M
    PLoS One; 2021; 16(2):e0247190. PubMed ID: 33596259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pretreatment with Lovastatin Improves Depression-Like Behavior After Traumatic Brain Injury Through Activation of the AMPK Pathway.
    Chen YT; Nyam TE; Tsai LC; Chang CH; Su CL; Ho CH; Chio CC; Gean PW; Kuo JR
    World Neurosurg; 2023 Dec; 180():e350-e363. PubMed ID: 37757945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of oxysterol binding protein-related protein 5 in pancreatic cancer.
    Ishikawa S; Nagai Y; Masuda T; Koga Y; Nakamura T; Imamura Y; Takamori H; Hirota M; Funakosi A; Fukushima M; Baba H
    Cancer Sci; 2010 Apr; 101(4):898-905. PubMed ID: 20128820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in dynamic modeling of colorectal cancer signaling-network regions, a path toward targeted therapies.
    Tortolina L; Duffy DJ; Maffei M; Castagnino N; Carmody AM; Kolch W; Kholodenko BN; De Ambrosi C; Barla A; Biganzoli EM; Nencioni A; Patrone F; Ballestrero A; Zoppoli G; Verri A; Parodi S
    Oncotarget; 2015 Mar; 6(7):5041-58. PubMed ID: 25671297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colorectal Cancer Cells Enter a Diapause-like DTP State to Survive Chemotherapy.
    Rehman SK; Haynes J; Collignon E; Brown KR; Wang Y; Nixon AML; Bruce JP; Wintersinger JA; Singh Mer A; Lo EBL; Leung C; Lima-Fernandes E; Pedley NM; Soares F; McGibbon S; He HH; Pollet A; Pugh TJ; Haibe-Kains B; Morris Q; Ramalho-Santos M; Goyal S; Moffat J; O'Brien CA
    Cell; 2021 Jan; 184(1):226-242.e21. PubMed ID: 33417860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Influence of Statin Use on Chemotherapeutic Efficacy in Studies of Mouse Models: A Systematic Review.
    Tulk A; Watson R; Erdrich J
    Anticancer Res; 2023 Oct; 43(10):4263-4275. PubMed ID: 37772570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statins markedly potentiate aminopeptidase inhibitor activity against (drug-resistant) human acute myeloid leukemia cells.
    Jansen G; Al M; Assaraf YG; Kammerer S; van Meerloo J; Ossenkoppele GJ; Cloos J; Peters GJ
    Cancer Drug Resist; 2023; 6(3):430-446. PubMed ID: 37842233
    [No Abstract]   [Full Text] [Related]  

  • 32. The Blocking of Drug Resistance Channels by Selected Hydrophobic Statins in Chemoresistance Human Melanoma.
    Placha W; Suder P; Panek A; Bronowicka-Adamska P; Zarzycka M; Szczygieł M; Zagajewski J; Piwowar MW
    Biomolecules; 2023 Nov; 13(12):. PubMed ID: 38136555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are statins onco- suppressive agents for every type of tumor? A systematic review of literature.
    Filaferro L; Zaccarelli F; Niccolini GF; Colizza A; Zoccali F; Grasso M; Fusconi M
    Expert Rev Anticancer Ther; 2024 Jun; 24(6):435-445. PubMed ID: 38609343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carvacrol alters soluble factors in HCT-116 and HT-29 cell lines.
    Pakdemirli A; Karaca C; Sever T; Daşkin E; Leblebici A; Yiğitbaşi T; Başbinar Y
    Turk J Med Sci; 2020 Feb; 50(1):271-276. PubMed ID: 31742371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring the Synergistic Effect of Simvastatin in Oral Health Applications: A Literature Review.
    Kabra S; Thosar NR; Malviya NS
    Cureus; 2023 Aug; 15(8):e44411. PubMed ID: 37791218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The BMP pathway either enhances or inhibits the Wnt pathway depending on the SMAD4 and p53 status in CRC.
    Voorneveld PW; Kodach LL; Jacobs RJ; van Noesel CJ; Peppelenbosch MP; Korkmaz KS; Molendijk I; Dekker E; Morreau H; van Pelt GW; Tollenaar RA; Mesker W; Hawinkels LJ; Paauwe M; Verspaget HW; Geraets DT; Hommes DW; Offerhaus GJ; van den Brink GR; Ten Dijke P; Hardwick JC
    Br J Cancer; 2015 Jan; 112(1):122-30. PubMed ID: 25393365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'stemness' via the bone morphogenetic protein pathway.
    Kodach LL; Jacobs RJ; Voorneveld PW; Wildenberg ME; Verspaget HW; van Wezel T; Morreau H; Hommes DW; Peppelenbosch MP; van den Brink GR; Hardwick JC
    Gut; 2011 Nov; 60(11):1544-53. PubMed ID: 21551187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholesterol metabolism and colorectal cancer: the plot thickens.
    Rzasa P; Rufini A
    Cell Death Discov; 2024 Jan; 10(1):3. PubMed ID: 38177141
    [No Abstract]   [Full Text] [Related]  

  • 39. Cholesterol in colorectal cancer: an essential but tumorigenic precursor?
    He X; Lan H; Jin K; Liu F
    Front Oncol; 2023; 13():1276654. PubMed ID: 38023258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Redrawing Urokinase Receptor (uPAR) Signaling with Cancer Driver Genes for Exploring Possible Anti-Cancer Targets and Drugs.
    Chang YC; Wu CZ; Cheng CW; Chen JS; Chang LC
    Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.